JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
JE FAIS UN DON
Assessment of risk practices and infectious disease among drug users in Tanzania
HIV prevalence is around 40% in people who inject drugs.
Although HIV in mainland Tanzania is characterised as a generalised epidemic, there is evidence that injecting drug use is contributing to high rates of HIV transmission among drug using groups, with growing concerns of the potential for onward transmission of HIV to non‐drug using populations. Evidence to date estimates that HIV prevalence is around 40% in people who inject drugs (PWID) in Tanzania,1 compared to approximately 6‐7% in the general population.3 Gender disparities in population HIV prevalence are also evident within groups of PWID, reaching as high as 64% among female PWID.